Search research articles
Contact Us
Filters
Showing results (361-370 of 419) with videos related to
Page
of 42
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1988
Androgen priming and chemotherapy in advanced prostate cancer: evaluation of determinants of clinical outcome
A Manni, M Bartholomew, R Caplan, et al.
The American Surgeon
|
April 2, 2004
Complications are increased with the need for an abdominal-assisted Kraske procedure
Elizabeth H Harvey, Michelle R Young, Thomas L Flanigan, et al.
Annals of Internal Medicine
|
March 15, 1993
Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamide-based chemotherapy. The Ondansetron Study Group
T M Beck, A A Ciociola, S E Jones, et al.
Journal of Steroid Biochemistry
|
January 1, 1987
Androgen depletion and repletion as a means of potentiating the effect of cytotoxic chemotherapy in advanced prostate cancer
A Manni, R J Santen, A E Boucher, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
June 6, 2003
Fluoxetine decreases stereotypic behavior in primates
Charmaine Hugo, Jurgen Seier, Chris Mdhluli, et al.
Clinical Chemistry
|
April 1, 1993
Increased urinary excretion of pyridinium cross-links in cancer patients
A Lipton, L Demers, Y Daniloff, et al.
Anticancer Research
|
May 1, 1984
Evaluation of CEA and GCDFP-15 plasma level during hormonally induced cancer stimulation
A Manni, R J Santen, A E Boucher, et al.
Radiography (London, England : 1995)
|
February 7, 2024
AI implementation in the UK landscape: Knowledge of AI governance, perceived challenges and opportunities, and ways forward for radiographers
N Stogiannos, T O'Regan, E Scurr, et al.
Seminars in Oncology
|
August 1, 1992
The delayed-emesis syndrome from cisplatin: phase III evaluation of ondansetron versus placebo
D R Gandara, W H Harvey, G G Monaghan, et al.
Epilepsy Research
|
November 12, 2017
Influence of titration schedule and maintenance dose on the tolerability of adjunctive eslicarbazepine acetate: An integrated analysis of three randomized placebo-controlled trials
Gregory Krauss, Victor Biton, Jay H Harvey, et al.
Page
of 42
Search research articles
Search
Showing results (361-370 of 419) with videos related to
Sort By:
Page
of 42
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1988
Androgen priming and chemotherapy in advanced prostate cancer: evaluation of determinants of clinical outcome
A Manni, M Bartholomew, R Caplan, et al.
The American Surgeon
|
April 2, 2004
Complications are increased with the need for an abdominal-assisted Kraske procedure
Elizabeth H Harvey, Michelle R Young, Thomas L Flanigan, et al.
Annals of Internal Medicine
|
March 15, 1993
Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamide-based chemotherapy. The Ondansetron Study Group
T M Beck, A A Ciociola, S E Jones, et al.
Journal of Steroid Biochemistry
|
January 1, 1987
Androgen depletion and repletion as a means of potentiating the effect of cytotoxic chemotherapy in advanced prostate cancer
A Manni, R J Santen, A E Boucher, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
June 6, 2003
Fluoxetine decreases stereotypic behavior in primates
Charmaine Hugo, Jurgen Seier, Chris Mdhluli, et al.
Clinical Chemistry
|
April 1, 1993
Increased urinary excretion of pyridinium cross-links in cancer patients
A Lipton, L Demers, Y Daniloff, et al.
Anticancer Research
|
May 1, 1984
Evaluation of CEA and GCDFP-15 plasma level during hormonally induced cancer stimulation
A Manni, R J Santen, A E Boucher, et al.
Radiography (London, England : 1995)
|
February 7, 2024
AI implementation in the UK landscape: Knowledge of AI governance, perceived challenges and opportunities, and ways forward for radiographers
N Stogiannos, T O'Regan, E Scurr, et al.
Seminars in Oncology
|
August 1, 1992
The delayed-emesis syndrome from cisplatin: phase III evaluation of ondansetron versus placebo
D R Gandara, W H Harvey, G G Monaghan, et al.
Epilepsy Research
|
November 12, 2017
Influence of titration schedule and maintenance dose on the tolerability of adjunctive eslicarbazepine acetate: An integrated analysis of three randomized placebo-controlled trials
Gregory Krauss, Victor Biton, Jay H Harvey, et al.
Page
of 42